FDA declines to approve NeurogesX patch for HIV pain
(Reuters) - U.S. health regulators declined to approve NeurogesX Inc's patch derived from chili peppers to treat HIV-related Pain and sought new trial data, and the company said it will cut half its workforce to save costs. The U.S. Food And Drug Administration told NeurogesX that to gain approval for the treatment, Qutenza, the company would need to submit additional clinical data from at least one adequate and well-controlled trial. ... read more..
source:http://yhoo.it/AD59du
No comments:
Post a Comment